The NLRP3 inflammasome: an emerging therapeutic target for chronic pain

被引：0
作者：
Ruixiang Chen
Chengyu Yin
Jianqiao Fang
Boyi Liu
机构：
[1] Zhejiang Chinese Medical University,Department of Neurobiology and Acupuncture Research, The Third Clinical Medical College
[2] Key Laboratory of Acupuncture and Neurology of Zhejiang Province,undefined
来源：
Journal of Neuroinflammation | / 18卷
关键词：
NLRP3; Caspase-1; Inflammasome; Inflammation; Interleukins; Pain;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Chronic pain affects the life quality of the suffering patients and posts heavy problems to the health care system. Conventional medications are usually insufficient for chronic pain management and oftentimes results in many adverse effects. The NLRP3 inflammasome controls the processing of proinflammatory cytokine interleukin 1β (IL-1β) and is implicated in a variety of disease conditions. Recently, growing number of evidence suggests that NLRP3 inflammasome is dysregulated under chronic pain condition and contributes to pathogenesis of chronic pain. This review provides an up-to-date summary of the recent findings of the involvement of NLRP3 inflammasome in chronic pain and discussed the expression and regulation of NLRP3 inflammasome-related signaling components in chronic pain conditions. This review also summarized the successful therapeutic approaches that target against NLRP3 inflammasome for chronic pain treatment.
引用
收藏
相关论文
共 722 条
  • [1] Dahlhamer J(2018)Prevalence of chronic pain and high-impact chronic pain among adults - United States, 2016 MMWR Morb Mortal Wkly Rep 67 1001-1006
  • [2] Lucas J(2020)Chemokines in chronic pain: cellular and molecular mechanisms and therapeutic potential Pharmacol Ther 212 107581-548
  • [3] Zelaya C(2014)Emerging targets in neuroinflammation-driven chronic pain Nat Rev Drug Discov 13 533-577
  • [4] Nahin R(2016)Pain regulation by non-neuronal cells and inflammation Science 354 572-14073
  • [5] Mackey S(2008)Nociceptors are interleukin-1beta sensors J Neurosci 28 14062-1275
  • [6] DeBar L(1995)Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia Br J Pharmacol 115 1265-13076
  • [7] Kerns R(2019)Transfer of complex regional pain syndrome to mice via human autoantibodies is mediated by interleukin-1-induced mechanisms Proc Natl Acad Sci U S A 116 13067-S20
  • [8] Von Korff M(2019)An update on reactive astrocytes in chronic pain J Neuroinflammation 16 140-4665
  • [9] Porter L(2019)THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets Br J Pharmacol 176 S1-1046
  • [10] Helmick C(2020)The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target J Neuroinflammation 17 104-2087
12345678910